SightMD’s Dr. Alanna Nattis Featured In Clinical Ophthalmology for The Treatment of Ocular Surface Disease & Meibomian Gland Dysfunction

In an article to help determine how bacteria within the Meibomian Glands influenced ocular surface disease, Dr. Nattis and her co-authors concluded that basic symptoms of the ocular surface disease do not necessarily correlate with clinical exam findings nor positive culture findings. They argued that the bacterial burden should be reconsidered as a direct risk factor and treatment target for patients with Meibomian gland dysfunction and ocular surface disease.

To read the complete article, please click this link.

LASIK Self TestCataract Self TestRate Us OnlineContinuing Education Events